Literature DB >> 10849920

The benefits of a hospital based community services liaison pharmacist.

K Brookes1, M G Scott, J B McConnell.   

Abstract

OBJECTIVE: To investigate the benefits of a community services liaison pharmacist in addressing medication misuse in elderly patients, which occur on both admission and discharge.
DESIGN: Completion of a medication history for each patient on admission by the community liaison pharmacist. On discharge updated medication record sheets were faxed to the patient's GP and community pharmacy; a survey of GPs' and community pharmacists' opinions who were involved in the study was carried out. SUBJECTS AND
SETTING: 109 patients over the age of 60 on 4 or more medications admitted by the medical admissions unit of Antrim Area Hospital. MAIN OUTCOME MEASURES: Medication related problems; GP and community pharmacist opinions of the service.
RESULTS: Of the 109 patients, 61% had an incomplete medication history on admission, 21% of patients who brought their own drugs were not dealt with appropriately in hospital and 33% of discharged patients had medication-related problems. The service was felt to be very useful by GPs (80%) and community pharmacists (100%). A reduction in readmission rate of 2.4% was seen in these patients compared to the average for this age group.
CONCLUSION: The community services liaison pharmacist produced benefits in terms of patient medication management, reduced readmission rates and wastage of patients' own drugs. A more detailed one-year study will now be carried out.

Entities:  

Mesh:

Year:  2000        PMID: 10849920     DOI: 10.1023/a:1008713304892

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  13 in total

1.  Survey Results: Community Liaison Programs to Cut Hospital Readmissions.

Authors:  Matthew Grissinger
Journal:  P T       Date:  2016-01

Review 2.  Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review.

Authors:  Vincent C Tam; Sandra R Knowles; Patricia L Cornish; Nowell Fine; Romina Marchesano; Edward E Etchells
Journal:  CMAJ       Date:  2005-08-30       Impact factor: 8.262

3.  Reduce readmissions with pharmacy programs that focus on transitions from the hospital to the community.

Authors:  Matthew Grissinger
Journal:  P T       Date:  2015-04

4.  ISMP Medication Error Report Analysis.

Authors: 
Journal:  Hosp Pharm       Date:  2013-03

5.  Drug related problems and pharmacist interventions in a geriatric unit employing electronic prescribing.

Authors:  Mélina Raimbault-Chupin; Laurence Spiesser-Robelet; Véronique Guir; Cédric Annweiler; Olivier Beauchet; Marie-Anne Clerc; Frédéric Moal
Journal:  Int J Clin Pharm       Date:  2013-07-16

Review 6.  Quality of medication use in primary care--mapping the problem, working to a solution: a systematic review of the literature.

Authors:  Sara Garfield; Nick Barber; Paul Walley; Alan Willson; Lina Eliasson
Journal:  BMC Med       Date:  2009-09-21       Impact factor: 8.775

7.  Improving communication of medication changes using a pharmacist-prepared discharge medication management summary.

Authors:  Choon Ean Ooi; Olivia Rofe; Michelle Vienet; Rohan A Elliott
Journal:  Int J Clin Pharm       Date:  2017-03-11

8.  Communicating medication changes to community pharmacy post-discharge: the good, the bad, and the improvements.

Authors:  Rachel Urban; Evgenia Paloumpi; Nooresameen Rana; Julie Morgan
Journal:  Int J Clin Pharm       Date:  2013-06-29

9.  Hospitalization Drug Regimen Changes in Geriatric Patients and Adherence to Modifications by General Practitioners in Primary Care.

Authors:  L Rouch; F Farbos; C Cool; C McCambridge; C Hein; S Elmalem; Y Rolland; B Vellas; P Cestac
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

10.  Informational needs of general practitioners regarding discharge medication: content, timing and pharmacotherapeutic advice.

Authors:  Fatma Karapinar; Patricia M L A van den Bemt; Jan Zoer; Giel Nijpels; Sander D Borgsteede
Journal:  Pharm World Sci       Date:  2010-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.